Abstract
This chapter provides a framework to ensure that STI services are adolescent and young adult-friendly and accessible and are provided in a context that considers potential barriers to accessing care and factors that increase in risk including vulnerability to assault, unpredictable living circumstances, past history of trauma, potential mental health problems and use of substances. Homeless youth may have had negative prior experiences and faced rejection that may create barriers to accessing medical care. Inclusive, non-stigmatizing and non-presumptive terminology is reviewed. The importance of protecting the confidentiality of patient medical records is emphasized. Environmental, behavioural and biologic risk factors for sexually transmitted infections for youth experiencing homelessness are reviewed. Approaches to prevention of STIs for adolescents and young adults (including the use of condoms, HPV vaccine and PrEP for prevention of HIV), clinical presentations, laboratory diagnosis and management of gonorrhoea, chlamydia, syphilis, HPV, HIV and other specific STIs, with specific considerations for homeless adolescents and youth, are provided.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Recognizing the broad diversity of sexual identity, sexual orientation and gender identity, we have taken measures in this chapter to ensure the language we use is inclusive and gender-affirming. We have attempted to avoid making assumptions about gender, preferring to use more specific language when appropriate (e.g. person with a cervix rather than female; recognizes that both cisgender females and transgender males may have a cervix). In some situations, particularly when reporting on epidemiologic trends, this was not possible, as most studies use ‘male’ and ‘female’ as exclusive gender categories. In these situations, we use the terms as reported. In some situations, for clarity of language, we have used the terms ‘biological female’ and ‘biological male’ to refer to individuals who were assigned that particular gender at birth or have the sexual anatomy associated with female or male sex.
References
Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004;36:6.
United States Centers for Disease Control and Prevention. 2015 Sexually transmitted diseases treatment guidelines. 2015. Available at: https://www.cdc.gov/std/tg2015/specialpops.htm#adol. Accessed 26 Mar 2019.
Public Health Agency of Canada. Canadian guidelines on sexually transmitted infections. 2019. Available at: https://www.canada.ca/en/public-health/services/infectious-diseases/sexual-health-sexually-transmitted-infections/canadian-guidelines/sexually-transmitted-infections.html#toc. Accessed 26 Mar 2019.
World Health Organization. Adolescent-friendly health services: an agenda for change. 2004. Available at: www.who.int/child_adolescent_health/documents/fch_cah_02_14/en/index.html. Accessed 15 Aug 2018.
Caccamo A, Kachur R, Williams SP. Narrative review: sexually transmitted diseases and homeless youth – what do we know about sexually transmitted disease prevalence and risk. Sex Transm Dis. 2017;44:466.
Marshall BD, Kerr T, Shoveller JA, Patterson TL, Buxton JA, Wood E. Homelessness and unstable housing associated with an increased risk of HIV and STI transmission among street-involved youth. Health Place. 2009;15(3):753.
Quality of Care. A process for making strategic choices in health systems. Geneva, World Health Organization; 2006; Quality Assessment Guidebook. A guide to assessing health services for adolescent clients. Geneva, World Health Organization; 2009.
Singer M. A dose of drugs, a touch of violence, a case of AIDS: conceptualizing the SAVA epidemic. Free Inq Creat Sociol. 1996;24:99.
Singer M. Introduction to syndemics: a systems approach to public and community health. San Francisco: Jossey-Bass; 2009.
Singer M, Bulled N, Ostrach B, Mendenhall E. Syndemic and the biosocial conception of health. Lancet. 2017;389:941.
Halkitis PN, Wolitski RJ, Millett GA. A holistic approach to addressing HIV infection disparities in gay, bisexual, and other men who have sex with men. Am Psychol. 2013;68(4):261.
Warf CW, Clark LF, Desai M, et al. Coming of age on the streets: survival sex among homeless young women in Hollywood. J Adolesc. 2013;36(6):1205–13.
Singer M, Bulled N, Ostrach B, Mendenhall E. Syndemics and the biosocial conception of health. Lancet. 2017;389:941.
Stall R, Mills TC, Williamson J, et al. Association of co-occurring psychosocial health problems and increased vulnerability to HIV/AIDS among urban men who have sex with men. Am J Public Health. 2003;93:939.
DiClemente RJ, Salazar LF, Crosby RA. A review of STD/HIV preventive interventions for adolescents: sustaining effects using an ecological approach. J Pediatr Psychol. 2007;32(8):888.
Sieving RE, Bernat DH, Resnick MD, et al. A clinic-based youth development program to reduce sexual risk behaviors among adolescent girls: prime time pilot study. Health Promot Pract. 2012;13(4):462.
Upchurch DM, Mason WM, Kusunoki Y, et al. Social and behavioral determinants of self reported STD among adolescents. Perspect Sex Reprod Health. 2004;36(6):276.
Charest M, Kleinplatz PJ, Lund JI. Sexual health information disparities between heterosexual and LGBTQ+ young adults: implications for sexual health. Can J Hum Sex. 2016;25:74.
Garcia CK. Sexual health education in Quebec schools: a critique and call for change. Can J Hum Sex. 2015;24:197.
Dbouba G, Shannon A. In: Chown S, editor. Sex ed is our right. Vancouver: YouthCO HIV & Hep C Society; 2018.
Cohen JN, Byers ES, Sears HA. Factors affecting Canadian teachers’ willingness to teach sexual health education. Sex Educ. 2011;12:1.
Manzer D, O’Sullivan LF, Doucet S. Myths, misunderstandings, and missing information: experiences of nurse practitioners providing primary care to lesbian, gay, bisexual, and transgender patients. Can J Hum Sex. 2018;27:157.
Smith A, Stewart D, Poon C, Peled M, Saewyc EM. Our communities, our youth. Vancouver: McCreary Centre Society; 2015.
Saewyc EM, Drozda C, Rivers R, MacKay L, Peled M. Which comes first: sexual exploitation or other risk exposures among street-involved youth? In: Youth homelessness in Canada: implications for policy and practice. Toronto: Canadian Homelessness Research Network; 2013.
Abramovich AI. No fixed address: young, queer, and restless. In: Gaetz S, et al., editors. Youth homelessness in Canada: implications for policy and practice. Toronto: Canadian Observatory on Homelessness; 2013.
Remafedi G, Resnick M, Blum R, Harris L. Demography of sexual orientation in adolescents. Pediatrics. 1992;89:714.
Forhan SE, Gottlieb SL, Sternberg MR, et al. Prevalence of sexually transmitted infections among female adolescents aged 14 to 19 in the United States. Pediatrics. 2009;124:1505.
CDC. Sexually transmitted disease surveillance 2013. Atlanta: US Department of Health and Human Services; 2014.
Tu W, Batteiger BE, Wiehe S, et al. Time from first intercourse to first sexually transmitted infection diagnosis among adolescent women. Arch Pediatr Adolesc Med. 2009;163(12):1106.
Kahn JA, Rosenthal SL, Succop PA, Ho GY, Burk RD. Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection. Pediatrics. 2002;109(1):E5.
Shew ML, Fortenberry JD, Miles P, Amortegui AJ. Interval between menarche and first sexual intercourse, related to risk of human papillomavirus infection. J Pediatr. 1994;125(4):661.
Burstein GR, Gaydos CA, Diener-West M, Howell MR, Zenilman JM, Quinn TC. Incident Chlamydia trachomatis infections among inner-city adolescent females. JAMA. 1998;280(6):521.
Niccolai LM, Ethier KA, Kershaw TS, Lewis JB, Meade CS, Ickovics JR. New sex partner acquisition and sexually transmitted disease risk among adolescent females. J Adolesc Health. 2004;34(3):216.
Fortenberry JD. Adolescent substance use and sexually transmitted diseases risk: a review. J Adolesc Health. 1995;16(4):304.
Leigh BC. Alcohol and condom use: a meta-analysis of event-level studies. J Adolesc Health. 1995;16(4):304.
Kleppa E, Holmen SD, Lillebø K, et al. Cervical ectopy: associations with sexually transmitted infections and HIV. A cross-sectional study of high school students in rural South Africa. Sex Transm Infect. 2015;91(2):124.
Hwang LY, Ma Y, Moscicki AB. Biological and behavioral risks for incident Chlamydia trachomatis infection in a prospective cohort. Obstet Gynecol. 2014;124(5):954.
McGrath JW, Strasburger VC, Cushing AH. Secretory IgA in cervical mucus. J Adolesc Health. 1994;15(5):423.
Hickey RJ, Zhou X, Settles ML, Erb J, Malone K, Hansmann MA, Shew ML, Van Der Pol B, Fortenberry JD, Forney LJ. Vaginal microbiota of adolescent girls prior to the onset of menarche resemble those of reproductive-age women. MBio. 2015;6(2):pii: e00097-15.
Seth P, Patel SN, Sales JM, DiClemente RJ, Wingood GM, Rose ES. The impact of depressive symptomatology on risky sexual behavior and sexual communication among African American female adolescents. Psychol Health Med. 2011;16(3):346.
Duron S, Panjo H, Bohet A, et al. Prevalence and risk factors of sexually transmitted infections among French service members. PLoS One. 2018;13(4):e0195158.
Trecker MA, Dillon JR, Lloyd K, Hennink M, Jolly A, Waldner C. Can social network analysis help address the high rates of bacterial sexually transmitted infections in Saskatchewan? Sex Transm Dis. 2017;44(6):338.
Cheng T, Johnston C, Kerr T, Nguyen P, Wood E, Debeck K. Substance use patterns and unprotected sex among street-involved youth in a Canadian setting: a prospective cohort study. BMC Public Health. 2016;16(10):4.
Gamarel KE, Brown L, Kahler CW, Fernandez MI, Bruce D, Nichols S. Prevalence and correlates of substance use among youth living with HIV in clinical settings. Drug Alcohol Depend. 2016;169:11.
Public Health Agency of Canada. Report on sexually transmitted infections in Canada: 2013–2014. Retrieved from: https://www.canada.ca/en/public-health/services/publications/diseases-conditions/report-sexually-transmitted-infections-canada-2013-14.html. Accessed 10 Aug 2018.
Centers for Disease Control and Prevention. STDs in adolescents and young adults. Available: https://www.cdc.gov/std/stats16/adolescents.htm. Accessed 10 Aug 2018.
Stamm WE. Chlamydia trachomatis infections of the adult. In: Holmes KK, Sparling PF, Mardh PA, et al., editors. Sexually transmitted diseases. 4th ed. New York: McGraw-Hill; 2008.
Cecil JA, Howell MR, Tawes JJ, et al. Features of Chlamydia trachomatis and Neisseria gonorrhoeae infection in male Army recruits. J Infect Dis. 2001;184(9):1216.
McCormack WM, Stumacher RJ, Johnson K, Donner A. Clinical spectrum of gonococcal infection in women. Lancet. 1977;1(8023):1182.
Sherrard J, Barlow D. Gonorrhoea in men: clinical and diagnostic aspects. Genitourin Med. 1996;72(6):422.
Handsfield HH, Lipman TO, Harnisch JP, Tronca E, Holmes KK. Asymptomatic gonorrhea in men. Diagnosis, natural course, prevalence and significance. N Engl J Med. 1974;290(3):117.
Klouman E, Masenga EJ, Sam NE, Klepp KI. Asymptomatic gonorrhoea and chlamydial infection in a population-based and work-site based sample of men in Kilimanjaro, Tanzania. Int J STD AIDS. 2000;11:666.
Geisler WM, Wang C, Morrison SG, Black CM, Bandea CI, Hook EW. The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment. Sex Transm Dis. 2008;35(2):119.
Fode M, Fusco F, Lipschultz L, Weidner W. Sexually transmitted disease and male infertility: a systematic review. Reprod Health. 2017;14(1):5.
Lieberman A, Badolato GM, Tran J, et al. Frequency of prescription filling among adolescents prescribed treatment for sexually transmitted infections in the emergency department. JAMA Pediatr. 2019; published online May 28, 2019. https://doi.org/10.1001/jamapediatrics.2019.1263.
Burchell AN, Allen VG, Gardner SL, et al. High incidence of diagnosis with syphilis co-infection among men who have sex with men in an HIV cohort in Ontario, Canada. BMC Infect Dis. 2015;15(1):356.
United States Centers for Disease Control and Prevention. Sexually transmitted disease surveillance. 2016. Available at: https://www.cdc.gov/std/stats16/Syphilis.htm. Accessed 10 Aug 2018.
Tramont EC. Treponema pallidum (Syphilis). In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. Philadelphia: Churchill-Livingstone; 2010. p. 3035–53.
Chapel TA. The signs and symptoms of secondary syphilis. Sex Transm Dis. 1980;7(4):161.
Young MF, Sanowski RA, Manne RA. Syphilitic hepatitis. J Clin Gastroenterol. 1992;15(2):174.
Risser WL, Hwang LY. Problems in the current case definitions of congenital syphilis. J Pediatr. 1996;129(4):499.
Dobson SR, Sanchez PJ. Syphilis. In: Cherry JD, Harrison GJ, Kaplan SL, et al., editors. Feigin and Cherry’s textbook of pediatric infectious diseases. 7th ed. Philadelphia: Elsevier Saunders; 2014. p. 1761.
The Lancet. Congenital syphilis in the USA. Lancet. 2018;392(10154):1168. https://doi.org/10.1016/S0140-6736(18)32360-2.
Reyes MP, Hunt N, Ostrea EM Jr, George D. Maternal/congenital syphilis in a large tertiary-care urban hospital. Clin Infect Dis. 1993;17(6):1041.
Caddy SC, Lee BE, Sutherland K, et al. Pregnancy and neonatal outcomes of women with reactive syphilis serology in Alberta, 2002 to 2006. J Obstet Gynaecol Can. 2011;33(5):453.
Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med. 1997;102(5A):3.
Bonnez W, Reichman RC. Papillomaviruses. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. Philadelphia: Churchill-Livingstone; 2010. p. 2035–49.
De Villers EM. Cross-roads in the classification of papillomaviruses. Virology. 2013;445:2.
Bouvard V, Baan R, Straif K, et al. A review of human carcinogens – part B: biological agents. Lancet Oncol. 2009;10:321.
Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ. 2001;164(7):1017.
Forman D, de Martel C, Lacey CJ, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30(Suppl 5):F12.
Backes DM, Kurman RJ, Pimenta JM, Smith JS. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control. 2009;20(4):449.
Hoots BE, Palefsky JM, Pimenta JM, Smith JS. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer. 2009;124(10):2375.
Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med. 2001;344(15):1125.
Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet. 2011;377(9783):2085.
Markowitz LE, Hariri S, Lin C, et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010. J Infect Dis. 2013;208(3):385.
Smith LM, Strumpf EC, Kaufman JS, Lofters A, Schwandt M, Lévesque LE. The early benefits of human papillomavirus vaccination on cervical dysplasia and anogenital warts. Pediatrics. 2015;135(5):e1131.
Giuliano AR, Palefsky JM, Goldstone S, et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med. 2011;364(5):401.
An advisory Committee Statement (ACS) National Advisory Committee on Immunization. Available: https://www.canada.ca/en/public-health/services/publications/healthy-living/9-valent-hpv-vaccine-clarification-minimum-intervals-between-doses-in-hpv-immunization-schedule.html. Accessed 10 Aug 2018.
Petrosky E, Bocchini JA, Hariri S, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. Available: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6411a3.htm. Accessed 10 Aug 2018.
Canada’s provincial and territorial routine (and catch-up) vaccination program for infants and children. Available: https://www.canada.ca/content/dam/phac-aspc/documents/services/provincial-territorial-immunization-information/childhood_schedule-05-2017.pdf. Accessed 10 Aug 2018.
Paul P, Fabio A. Literature review of HPV vaccine delivery strategies: considerations for school- and non-school based immunization program. Vaccine. 2014;32:320.
Oliver SE, Unger ER, Lewis R, et al. Prevalence of human papillomavirus among females after vaccine introduction-National Health and Nutrition Examination Survey, United States, 2003–2014. J Infect Dis. 2017;216(5):594.
Ogilvie GS, Remple VP, Marra F, et al. Parental intention to have daughters receive the human papillomavirus vaccine. Can Med Assoc J. 2007;177:1506.
Hendry M, Lewis R, Clements A, et al. “HPV? Never heard of it!”: a systematic review of girls’ and parents’ information needs, views and preferences about human papillomavirus vaccination. Vaccine. 2013;31:5152.
Ogilvie GS, Phan F, Pedesen HN, Dobson SR, Naus M, Saewyc EM. Population-level sexual behaviours in adolescent girls before and after introduction of the human papillomavirus vaccine (2003–2013). Can Med Assoc J. 2018;190(41):E1221.
Kissinger P. Epidemiology and treatment of trichomoniasis. Curr Infect Dis Rep. 2015;17(6):484.
Landers DV, Wiesenfeld HC, Heine RP, Krohn MA, Hillier SL. Predictive value of the clinical diagnosis of lower genital tract infection in women. Am J Obstet Gyncol. 2004;190(4):1004.
United States Centers for Disease Control and Prevention. 2015 Sexually transmitted diseases treatment guidelines. 2015. Available at: https://www.cdc.gov/std/tg2015/trichomoniasis.htm. Accessed 28 Mar 2019.
Krieger JN, Tam MR, Stevens CE, et al. Diagnosis of trichomoniasis. Comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens. JAMA. 1988;259(8):1223.
Miller JM, Binnicker MJ, Campbell S, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2018;67(6):e1.
Ko CJ, Elston DM. Pediculosis. J Am Acad Dermatol. 2004;50:1.
Heukelbach J, Feldmeier H. Scabies. Lancet. 2006;367(9524):1767.
World Health Organization. HIV and youth. Available: www.who.int/maternal_child_adolescent/topics/adolescence/hiv/en/. Accessed 10 Aug 2018.
Bourgeois AC, Edmunds M, Awan A, et al. HIV in Canada – surveillance report, 2016. Can Commun Dis Rep. 2017;43:248.
Centers for Disease Control and Prevention (CDC). Vital signs: HIV infection, testing, and risk behaviors among youths – United States. MMWR Morb Mortal Wkly Rep. 2012;61(47):971.
Society for Adolescent Health and Medicine. HIV pre-exposure prophylaxis medication for adolescents and young adults: a position paper of the Society for Adolescent Health and Medicine. J Adolesc Health. 2018;63:513.
Matthews DD, Herrick AL, Coulter RW, et al. Running backwards: consequences of current HIV incidence rates for the next generation of Black MSM in the United States. AIDS Behav. 2016;20:7.
Grant RM, Lama JR, Anderson PL, et al. iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587.
Baeten JM, Donnell D, Ndase P, et al. Partners PrEP Study Team. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399.
Thigpen MC, Kebaabetswe PM, Paxton LA, et al. TDF2 Study Group. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423.
Grant RM, Anderson PL, McMahan V, et al. iPrEx study team. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14(9):820.
McCormack S, Dunn DT, Desai M, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53.
Liu AY, Cohen SE, Vittinghoff E, et al. Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services. JAMA Intern Med. 2016;176(1):75.
Molina JM, Capiatant C, Spire B, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373:2273.
Hosek SG, Landovitz RJ, Kapogiannis B, et al. Safety and feasibility of antiretroviral preexposure prophylaxis for adolescent men who have sex with men aged 15 to 17 years in the United States. JAMA Pediatr. 2017;171:1063.
LeFevre ML, US Preventive Services Task Force. Screening for chlamydia and gonorrhea: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;161(12):902–10.
Michielsen K, De Meyer S, Ivanova O, et al. Reorienting adolescent sexual and reproductive health research: reflections from an international conference. Reprod Health. 2016;13:3.
Halpern CT. Same-sex attraction and health disparities: do sexual minority youth really need something different for healthy development? J Adolesc Health. 2011;48:5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Grennan, T., Edward, J., Chown, S. (2020). Sexually Transmitted Infections and Sexual Healthcare of Homeless and Street-Involved Youth. In: Warf, C., Charles, G. (eds) Clinical Care for Homeless, Runaway and Refugee Youth. Springer, Cham. https://doi.org/10.1007/978-3-030-40675-2_12
Download citation
DOI: https://doi.org/10.1007/978-3-030-40675-2_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-40674-5
Online ISBN: 978-3-030-40675-2
eBook Packages: MedicineMedicine (R0)